Drugs / SaiLuoTong
SaiLuoTong
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT03789760 | Apr 2019 → Mar 2024 | vascular dementia | Shineway Pharmaceutical Co.,Ltd | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SaiLuoTong | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03789760 ↗ |
| Known as | SaiLuoTong capsule | “SaiLuoTong capsule is a traditional Chinese medicine compound;” NCT03789760 ↗ |
| Known as | SLT | “SaiLuoTong (SLT)” NCT03789760 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “SaiLuoTong capsule is a traditional Chinese medicine compound;” NCT03789760 ↗ |
| Route | Oral | “take two pills(120mg) of SaiLuoTong capsule each time” NCT03789760 ↗ |